BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that its Executive Vice President and Chief Financial Officer, Brian Mueller, will be presenting at the 22nd Annual Morgan Stanley Global Healthcare Conference. The presentation is scheduled for Thursday, September 5, 2024, at 7:45 AM PT / 10:45 AM ET in New York, NY.
Investors and interested parties can access a live audio webcast of the presentation through the company's website at https://investors.biomarin.com/. For those unable to attend or listen live, an archived version of the remarks will be available on the company's website for a time following the conference.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha annunciato che il suo Vicepresidente Esecutivo e Direttore Finanziario, Brian Mueller, presenterà alla 22ª Conferenza Annuale Morgan Stanley sul Settore Sanitario Globale. La presentazione è programmata per giovedì 5 settembre 2024, alle 7:45 AM PT / 10:45 AM ET a New York, NY.
Investitori e parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web dell'azienda all'indirizzo https://investors.biomarin.com/. Per coloro che non possono partecipare o ascoltare in diretta, sarà disponibile una versione registrata delle dichiarazioni sul sito web dell'azienda per un periodo di tempo successivo alla conferenza.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha anunciado que su Vicepresidente Ejecutivo y Director Financiero, Brian Mueller, presentará en la 22ª Conferencia Anual de Salud Global de Morgan Stanley. La presentación está programada para el jueves 5 de septiembre de 2024, a las 7:45 AM PT / 10:45 AM ET en Nueva York, NY.
Los inversores y partes interesadas pueden acceder a una transmisión de audio en vivo de la presentación a través del sitio web de la empresa en https://investors.biomarin.com/. Para aquellos que no puedan asistir o escuchar en vivo, habrá una versión archivada de las declaraciones disponible en el sitio web de la empresa durante un tiempo después de la conferencia.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)는 최고재무책임자(CFO)인 브라이언 뮬러(Brian Mueller)가 제22회 모건스탠리 글로벌 헬스케어 회의에서 발표할 것이라고 발표했습니다. 발표는 2024년 9월 5일 목요일, 오전 7시 45분 PT / 오전 10시 45분 ET에 뉴욕에서 진행됩니다.
투자자 및 이해관계자는 회사 웹사이트 https://investors.biomarin.com/를 통해 발표의 실시간 오디오 웹캐스트에 접속할 수 있습니다. 참석하거나 실시간으로 듣지 못하는 분들은 회의 후 일정 기간 동안 회사 웹사이트에서 발언 내용의 녹화본을 이용할 수 있습니다.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) a annoncé que son Vice-Président Exécutif et Directeur Financier, Brian Mueller, présentera lors de la 22e Conférence Annuelle Morgan Stanley sur la Santé Mondiale. La présentation est prévue pour jeudi 5 septembre 2024, à 7h45 PT / 10h45 ET à New York, NY.
Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de la présentation via le site web de la société à l'adresse https://investors.biomarin.com/. Pour ceux qui ne peuvent pas assister ou écouter en direct, une version archivée des déclarations sera disponible sur le site de l'entreprise pendant un certain temps après la conférence.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hat angekündigt, dass sein Executive Vice President und Chief Financial Officer, Brian Mueller, auf der 22. jährlichen Morgan Stanley Global Healthcare-Konferenz präsentieren wird. Die Präsentation ist für Donnerstag, den 5. September 2024, um 7:45 Uhr PT / 10:45 Uhr ET in New York, NY, angesetzt.
Investoren und interessierte Parteien können über die Unternehmenswebsite auf einen Live-Audio-Webcast der Präsentation zugreifen unter https://investors.biomarin.com/. Für diejenigen, die nicht teilnehmen oder live zuhören können, wird eine archivierte Version der Äußerungen für eine Zeit nach der Konferenz auf der Unternehmenswebsite zur Verfügung stehen.
- None.
- None.
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | 650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-22nd-annual-morgan-stanley-global-healthcare-conference-on-thursday-september-5-at-745-am-pt--1045-am-et-in-new-york-ny-302233312.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When is BioMarin (BMRN) presenting at the Morgan Stanley Global Healthcare Conference?
Who will be representing BioMarin (BMRN) at the Morgan Stanley Global Healthcare Conference?
How can I listen to BioMarin's (BMRN) presentation at the Morgan Stanley conference?
Will BioMarin's (BMRN) presentation at the Morgan Stanley conference be available after the event?
What is the full name of the conference BioMarin (BMRN) is attending in September 2024?
